Generics 15

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Doripenem manufacturers

15 products found

Filters

15 products found

doripenem

Solution for injection 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

doripenem

Solution for injection 250mg

Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

doripenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700

Manufacturer usually replies in 5 days

doripenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19124

Manufacturer usually replies in 2 days

doripenem

Solution for injection/infusion 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17145

Manufacturer usually replies in 4 days

doripenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17145

Manufacturer usually replies in 4 days

doripenem

Solution for injection 250mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #1390

Manufacturer usually replies in 5 days

doripenem

Injection 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #638

Manufacturer usually replies in 8 days

doripenem

Powder for solution for infusion 0.5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
ID
Manufacturer #20982

Manufacturer usually replies in 9 days

doripenem

Injection 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

doripenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19203

Manufacturer usually replies in 6 days

doripenem

Injection 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18256

Manufacturer usually replies in 6 days

doripenem

Solution for injection/infusion 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

doripenem

Injection 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Manufacturer usually replies in 13 days

doripenem

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19827

Manufacturer usually replies in 103 days

Doripenem

Doripenem is an antibiotic of the Carbapenem class. It is a beta-lactam antibiotic capable of killing Pseudomonas aeruginosa. Doripenem is used to treat bacterial infections namely complex abdominal infections, pneumonia contracted in hospital, and complicated infections of the urinary tract including sepsis in the kidney infection. It has greater stability in aqueous solution compared to other Carbapenem class antibiotics. Doripenem is administered as an infusion over 4 hours or more, which is an advantage when treating difficult-to-treat infections. It also has a lower risk associated with inducing seizures than other Carbapenem. Doripenem is sold under the brand names Doribax and Finibax amongst others. Shionogi Co. of Japan launched it under the brand name in 2005 and is marketed outside Japan by Johnson & Johnson. Doripenem was approved by the USFDA in 2007, to be sold as Doribax. It is the fourth carbapenem class drug to get approval in the United States. USFDA later revised the Doripenem label in 2014 to include a warning against use in ventilator-associated pneumonia while reiterating its safety and efficacy for its approved indications.

Forms and Dosage

Doripenem is sold as a powder for injection in a 500 mg vial. In the treatment of Complicated Intra- abdominal Infection, the prescribed adult dosage is 500 mg IV infusion over 1 hour, given every 8hr for 5-14 days. if there is an improvement in the condition, the doctor may switch to PO treatment. In the treatment of Complicated UTI, the standard prescribed dose is 500 mg IV infusion over 1 hour given every 8 hours for 10 days, which can be extended up to 14 days if needed. In the treatment of Bronchopulmonary infection in patients with cystic fibrosis and who are colonized with Pseudomonas aeruginosa or Burkholderia cepacia.

The Price of Doripenem

In the USA, the consumers pay around $182 for Doripenem intravenous powder for injection 250 mg for a supply of 10 powder for injection. In the developing world countries, especially in India, the medicine is significantly cheaper with the generic versions, with a starting price of the only USD20 for the same 500 mg vial of powder for injection.

How does Doripenem work?

Doripenem is a beta-lactam antibiotic agent with a broad spectrum of bacterial sensitivity including both gram-positive and gram-negative bacteria. In vivo, Doripenem blocks the synthesis of cell walls by attaching itself to penicillin-binding proteins, But, it is not active against MRSA. Just like other beta- lactam antibiotics, Its bactericidal actions mostly due to cell death after inhibition of bacterial enzymes called penicillin-binding proteins.

Finding Doripenem Manufacturers and Suppliers

The process of finding trusted Doripenem manufacturers and Doripenem suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Doripenem. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.